News

Novavax shares soar after FDA request raises hope for COVID vaccine approval
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
FDA asks Novavax for post-approval data on COVID vaccine, shares soar
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full approval, sending the drugmaker's shares soaring and easing concerns around the ...
FDA asks Novavax for post-approval data on COVID vaccine, raising hopes for green light
The company is seeking to convert the vaccine’s emergency use authorization received in 2022 into a full approval that would ...
Agenus price target lowered to $8 from $11 at B. Riley
B. Riley analyst Mayank Mamtani lowered the firm’s price target on Agenus (AGEN) to $8 from $11 and keeps a Buy rating on the shares. The firm ...